Manasi Jaiman's most recent trade in Aardvark Therapeutics Inc. was a trade of 70,549 Stock option (right to buy) done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics Inc | Manasi Jaiman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 70,549 | 70,549 | - | - | Stock option (right to buy) | |
| Aardvark Therapeutics Inc | Manasi Jaiman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 126,999 | 126,999 | - | - | Stock Option (right to buy) |